Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - amoxicillin sodium 530.1mg equivalent to amoxicillin 500 mg;  ; potassium clavulanate 119.13mg equivalent to clavulanic acid 100 mg;  ;  ;   - powder for injection - 600 mg - active: amoxicillin sodium 530.1mg equivalent to amoxicillin 500 mg   potassium clavulanate 119.13mg equivalent to clavulanic acid 100 mg       - augmentin is indicated for the short term treatment of common bacterial infections such as: -upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media -lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho-pneumonia -genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections -skin and soft tissue infections -bone and joint infections: e.g. osteomyelitis -other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis, post-surgical infections augmentin is indicated for prophylaxis against infection which may be associated with major surgical procedures such as gastro-intestinal, pelvic, head and neck, cardiac, renal, joint replacement and biliary tract surgery.

Singapore - inglese - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - warfarin sodium - tablet - 3 mg - warfarin sodium 3 mg

Singapore - inglese - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - warfarin sodium - tablet - 5 mg - warfarin sodium 5 mg

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - warfarin sodium 1mg - tablet - 1 mg - active: warfarin sodium 1mg excipient: indigo carmine iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch pregelatinised maize starch sodium starch glycolate - coronary occlusion; deep vein thrombosis; pulmonary embolism; peripheral vascular thromboembolic states.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - warfarin sodium 3mg - tablet - 3 mg - active: warfarin sodium 3mg excipient: indigo carmine lactose monohydrate magnesium stearate maize starch pregelatinised maize starch sodium starch glycolate - coronary occlusion; deep vein thrombosis; pulmonary embolism; peripheral vascular thromboembolic states.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - warfarin sodium 5mg - tablet - 5 mg - active: warfarin sodium 5mg excipient: erythrosine lactose monohydrate magnesium stearate maize starch pregelatinised maize starch sodium starch glycolate - coronary occlusion; deep vein thrombosis; pulmonary embolism; peripheral vascular thromboembolic states.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - potassium clavulanate 128mg equivalent to clavulanic acid 100 mg (based on 82% potency +5% overage);  ; ticarcillin sodium 3.838 g equivalent to ticarcillin 3 g (based on 82% potency +5% overage) - powder for injection - active: potassium clavulanate 128mg equivalent to clavulanic acid 100 mg (based on 82% potency +5% overage)   ticarcillin sodium 3.838 g equivalent to ticarcillin 3 g (based on 82% potency +5% overage) - the treatment of infections caused by susceptible strains of organisms in the conditions listed below: - septicaemia (including bacteraemia) - lower respiratory tract infections - bone and joint infections - skin and skin structure infections - urinary tract infections - gynaecological infections - surgical prophylaxis appropriate culture and susceptibility tests should be performed in order to isolate and identify organisms causing infection and to determine their susceptibility to timentin. susceptibility to timentin will vary with geography and time and local succeptibility data should be consulted where available. in certain infections, when the causative organisms are unknown, timentin may be administered in conjunction with an aminoglycoside as initial therapy. as soon as results of culture and susceptibility tests become available, antimicrobial therapy should be adjusted as indicated. may be administered perioperatively (preoperatively, intraoperatively and postoperatively) to patients undergoing vaginal hysterectomy, abdominal surgery, and colorectal surgery when there is a significant risk of postoperative infection or where occurrence of postoperative infection is considered to be especially serious.

Singapore - inglese - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - warfarin sodium - tablet - 1 mg - warfarin sodium 1 mg

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - warfarin sodium - oral tablet - 5mg

Australia - inglese - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - warfarin sodium -